Thalidomide Maintenance in Multiple Myeloma: Certainties and Controversies Reply

被引：1
|
作者：
Spencer, Andrew [1 ]
Prince, H. Miles [2 ]
Roberts, Andrew W. [3 ]
机构：
[1] Alfred Hosp, Melbourne, Vic, Australia
[2] Peter MacCallum Canc Inst, Melbourne, Vic 3000, Australia
[3] Royal Melbourne Hosp, Melbourne, Vic, Australia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 32期
关键词：
CONSOLIDATION THERAPY; SURVIVAL;
D O I：
10.1200/JCO.2009.24.0853
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E188 / E188
页数：1
相关论文
共 50 条
  • [1] Thalidomide Maintenance in Multiple Myeloma: Certainties and Controversies
    Cavo, Michele
    Pantani, Lucia
    Tacchetti, Paola
    Pallotti, Maria Caterina
    Brioli, Annamaria
    Petrucci, Alessandro
    Zamagni, Elena
    Tosi, Patrizia
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (32) : E186 - E187
  • [2] Thalidomide maintenance in multiple myeloma
    Laubach, Jacob P.
    Richardson, Paul G.
    Anderson, Kenneth C.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2009, 6 (10) : 565 - 566
  • [3] The role of maintenance thalidomide therapy in multiple myeloma: MRC Myeloma IX results and meta-analysis
    Morgan, Gareth J.
    Gregory, Walter M.
    Davies, Faith E.
    Bell, Sue E.
    Szubert, Alexander J.
    Brown, Julia M.
    Coy, Nuria N.
    Cook, Gordon
    Russell, Nigel H.
    Rudin, Claudius
    Roddie, Huw
    Drayson, Mark T.
    Owen, Roger G.
    Ross, Fiona M.
    Jackson, Graham H.
    Child, J. Anthony
    BLOOD, 2012, 119 (01) : 7 - 15
  • [4] Biologically defined risk groups can be used to define the impact of thalidomide maintenance therapy in newly diagnosed multiple myeloma
    Brioli, Annamaria
    Kaiser, Martin F.
    Pawlyn, Charlotte
    Wu, Ping
    Gregory, Walter M.
    Owen, Roger
    Ross, Fiona M.
    Jackson, Graham H.
    Cavo, Michele
    Davies, Faith E.
    Morgan, Gareth J.
    LEUKEMIA & LYMPHOMA, 2013, 54 (09) : 1975 - 1981
  • [5] Sequential Bortezomib, Dexamethasone, and Thalidomide Maintenance Therapy after Single Autologous Peripheral Stem Cell Transplantation in Patients with Multiple Myeloma
    Sahebi, Firoozeh
    Frankel, Paul H.
    Farol, Len
    Krishnan, Amrita Y.
    Cai, Ji-lian
    Somlo, George
    Thomas, Sandra H.
    Reburiano, Eunicia
    Popplewell, Leslie L.
    Parker, Pablo M.
    Spielberger, Ricardo T.
    Karanes, Chatchada
    Htut, Myo
    Ruel, Christopher
    Duarte, Lupe
    Murata-Collins, Joyce L.
    Forman, Stephen J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (03) : 486 - 492
  • [6] Clinical Experience with Thalidomide and Lenalidomide in Multiple Myeloma
    Moehler, T.
    CURRENT CANCER DRUG TARGETS, 2012, 12 (04) : 372 - 390
  • [7] Maintenance Therapy for Multiple Myeloma
    McCarthy, Philip L.
    Palumbo, Antonio
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2014, 28 (05) : 839 - +
  • [8] A randomized phase 3 study on the effect of thalidomide combined with adriamycin, dexamethasone, and high-dose melphalan, followed by thalidomide maintenance in patients with multiple myeloma
    Lokhorst, Henk M.
    van der Holt, Bronno
    Zweegman, Sonja
    Vellenga, Edo
    Croockewit, Sandra
    van Oers, Marinus H.
    Borne, Peter von dem
    Wijermans, Pierre
    Schaafsma, Ron
    de Weerdt, Okke
    Wittebol, Shulamiet
    Delforge, Michel
    Berenschot, Henriette
    Bos, Gerard M.
    Jie, Kon-Siong G.
    Sinnige, Harm
    van Marwijk-Kooy, Marinus
    Joosten, Peter
    Minnema, Monique C.
    van Ammerlaan, Rianne
    Sonneveld, Pieter
    BLOOD, 2010, 115 (06) : 1113 - 1120
  • [9] Maintenance therapy for multiple myeloma in the era of novel agents
    Facon, Thierry
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2015, : 279 - 285
  • [10] Consolidation and maintenance therapy of multiple myeloma
    Zojer, N.
    Ludwig, H.
    ONKOLOGE, 2014, 20 (03): : 242 - 249
12345